OUR TEAM

FOUNDERS

Dr. Moshik Cohen-Kutner

Co-Founder And CEO

Linkedin

Dr. Niv Bachnoff

Co-Founder And CSO

Linkedin

BOARD OF DIRECTORS

Dr. Antonius Schuh

Chairman Of The Board Of Directors

Dr. Yafit Stark

Director, Regulatory And Clinical Advisor

Linkedin
Linkedin

Ori Choshen

Director

Michel Habib

Director

Linkedin
Linkedin

Eyal Dior

Director

Linkedin

SCIENTIFIC ADVISORY

Prof. Roger D. Kornberg

Advisory

Dr. Lynn L. Silver

Microbiology Development Advisory

Prof. Yehuda Carmeli, MD

Medical Advisory

Dr. Michael Mizhiritzkii

CMC Advisory

OMNIX TEAM

Lihi Elyahu BA

VP Operations & Human Resources

Bella Shusterman MSc Pharm

VP Clinical Development

Shira Mandel MSc

VP Research & Discovery

Noa Nur BSc Med, Biomed MBA

Director of Drug Discovery & Platform Development, IP Portfolio Manager

Jonathan Zazoun PharmD PhD

Head of CMC and Non-Dilutive Funding

Tamar Shachar BPharm, MSc

VP Strategy and Drug Development

Ofra Barchad-Avitzur, PhD

Senior Director of Clinical Affairs

Shelly Maximov BSc Eng, Data Science MBA

Director of Preclinical Development & Regulation

Elital Chass-Maurice MSc

Director of Clinical Operation

Orel Mayost Lev-Ari MSc

Research Associate

Inbal Doron, M.Sc

Research Associate

Ori Heyman PhD

Scientific Manager of In Vivo Research

Amir Ben-Dror BSc Eng

Project Manager

Meirav Belo

Office Manager

Deborah Mimoun, B.Sc. 

Clinical Operations Associate

Tomer Goldberg

Vice President, Managing Director Harel Technology Investments at Harel Insurance & Finance

Ran Achituv

Quantum & Deep-tech investor, Entree Capital & Chairman of Advisory Board and Alumni at Efi Arazi School of Computer Science

Contact Us

Reach US

Linkedin Twitter

A-2-Z - Digital Accessibility and Marketing

 

Omnix Medical Ltd. is committed to making its website and all its electronic information easier to use and more accessible for people with disabilities. The company’s website was created and/or updated according to the provisions of the Equal Rights for People with Disabilities Law, 5748-1998, and the delegated legislation stemming from it, and it fully complies with the W3C Web Content Accessibility Guidelines 2.0, AA level.


Omnix Medical Ltd. will continue its efforts to constantly improve the accessibility of its website and information in the belief that it is our collective moral obligation to allow seamless, accessible, and unhindered use also for those of us with disabilities.

  

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 966627 (OMNIX MEDICAL).